CD274 and ovarian neoplasm: Thus, the authors showed that by combining paclitaxel treatment with anti-PD-L1 or anti-PD1 antibodies, the immunosuppressive TME is attenuated, enabling the achievement of maximal antitumoral responses and increasing survival of ovarian tumor-bearing mice [83].